aTyr Pharma Inc
ATYR
NASDAQ
Biotechnology
$0.56
USD
+0.01 (+1.08%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $56.90M
Volume 648.1K
Price Target
$3.50 – $3.50
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $3.50 and a min estimate of $3.50.
Past 2Y
1Y Forecast
Price Targets
Average Target
$3.50
Implied Upside
+525.0%
Analyst Covering
1
Consensus
Buy
Signal Quality
Consensus Freshness
100%
Most ratings are recent - from the last 3 months
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Ilya Zubkov | Freedom Capital Markets | Buy | Upgraded | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
